Skip to main content

 Related scientific articles (all)

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.

Authors : Brouwers B, Hatse S, Dal Lago L, Neven P, Vuylsteke P, Dalmasso B, Debrock G, Van den Bulck H, Smeets A, Bechter O, Kini Bailur J, Kenis C, Laenen A, Schöffski P, Pawelec G, Journe F, Ghanem G, Wildiers H
Year : 2016
Journal : Oncotarget
Volume : 7(21)
Pages : 29977-88

Guidance for the prevention and treatment of venous thromboembolism in cancer patients

Authors : Awada A, Baurain JF, Clement P, Hainaut P, Holbrechts S, Hougardy JM, Jochmans K, Mathieu V, Mebis J, Strijbos MH, Vulsteke C, Verheij M
Year : 2016
Journal : Belgian J Medical Oncology
Volume : 7(6)
Pages : 217-23

Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design.

Authors : Kourie HR, Aoun F
Year : 2016
Journal : Invest New Drugs
Volume : 34(4)
Pages : 513-4

A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators.

Authors : Kenis C, Heeren P, Decoster L, Van Puyvelde K, Conings G, Cornelis F, Cornette P, Moor R, Luce S, Libert Y, Van Rijswijk R, Jerusalem G, Rasschaert M, Langenaeken C, Baitar A, Specenier P, Geboers K, Vandenborre K, Debruyne PR, Vanoverbeke K, Van den Bulck H, Praet JP, Focan C, Verschaeve V, Nols N, Goeminne JC, Petit B, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Year : 2016
Journal : J Nutr Health Aging
Volume : 20
Pages : 60-70

Levator Ani Necrosis: An Exceptional Complication Occurring after High Intensity Focused Ultrasound" of the Prostate."

Authors : Badawy D, El Rassy E, Aoun F, Van Velthoven R
Year : 2016
Journal : Case Rep Urol
Volume : 2016
Pages : 3920976

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Authors : Sideris S, Aoun F, Zanaty M, Martinez NC, Latifyan S, Awada A, Gil T
Year : 2016
Journal : Mol Clin Oncol
Volume : 4
Pages : 1063-1067

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells.

Authors : Najar M, Fayyad-Kazan M, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Year : 2016
Journal : Data Brief
Volume : 8
Pages : 1111-4

Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge.

Authors : Kourie HR, Tabchi S, Kattan J
Year : 2016
Journal : Future Oncol
Volume : 12(12)
Pages : 1435-7

The Future of Access to Innovative Medicines in Cancer Therapy: Towards Conditional Dialogue Fostering Affordable Therapeutic Innovation

Authors : van Dyk N, De Greve J, Schots R, Awada A, Van Eycken L, Geldof T
Year : 2016
Journal : Vlerick business school
Volume : 7
Pages : -

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

Authors : Morgan G, Lambertini M, Kourie HR, Amaral T, Argiles G, Banerjee S, Cardone C, Corral J, De Mattos-Arruda L, Öztürk A, Petrova M, Poulsen L, Strijbos M, Tyulyandina A, Vidra R, Califano R, de Azambuja E, Garrido Lopez P, Guarneri V, Reck M, Moiseyenko V, Martinelli E, Douillard JY, Stahel R, Voest E, Arnold D, Cardoso F, Casali P, Cervantes A, Eggermont AM, Eniu A, Jassem J, Pentheroudakis G, Peters S, McGregor K, Rauh S, Zielinski CC, Ciardiello F, Tabernero J, Preusser M
Year : 2016
Journal : ESMO Open
Volume : 1
Pages : e000107

Breast cancer in 2015: Academic research sheds light on issues that matter to patients.

Authors : Piccart-Gebhart M, Gingras I
Year : 2016
Journal : Nat Rev Clin Oncol
Volume : 13
Pages : 67-8

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be th

Authors : Viale G, Slaets L, de Snoo FA, Bogaerts J, Russo L, van t Veer L, Rutgers E, Piccart-Gebhart M, Stork-Sloots L, Dell orto P, Glas A, Cardoso F
Year : 2016
Journal : Breast Cancer Res Treat
Volume : 155(3)
Pages : 463-9

Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.

Authors : Roufosse F, Heimann P, Lambert F, Sidon P, Bron D, Cottin V, Cordier JF
Year : 2016
Journal : Respiration
Volume : 91
Pages : 374-9

Survey on skin-lightening practices and cosmetics in Kigali, Rwanda.

Authors : Kamagaju L, Morandini R, Gahongayire F, Stévigny C, Ghanem G, Pirotte G, Duez P
Year : 2016
Journal : Int J Dermatol
Volume : 55(1)
Pages : 45-51

Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.

Authors : Goris Gbenou MC, Peltier A, Schulman CC, Velthoven Rv
Year : 2016
Journal : Urol Oncol
Volume : 34(6)
Pages : 254.e1-6

Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?

Authors : Lewalle P, Wittnebel S
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 390-7

EGFR mutation status on brain metastases from non-small cell lung cancer.

Authors : Hsu F, De Caluwe A, Anderson D, Nichol A, Toriumi T, Ho C
Year : 2016
Journal : Lung Cancer
Volume : 96
Pages : 101-7

Progressive multifocal leukoencephalopathy mimicking cerebral metastases in a patient treated for nasopharyngeal carcinoma

Authors : Oualla K, Aoun F, Lemort M, Harrouk A, Latifyan S, Awada A, Georgala A
Year : 2016
Journal : Belgian J Medical Oncology
Volume : 10(7)
Pages : 276-280

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Authors : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EGE, Piccart-Gebhart M
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 205-207

Characterization of human breast cancer tissues by infrared imaging.

Authors : Verdonck M, Denayer A, Delvaux B, Garaud S, de Wind R, Desmedt C, Sotiriou C, Willard-Gallo K, Goormaghtigh E
Year : 2016
Journal : Analyst
Volume : 141(2)
Pages : 606-19